On the other hand, studies on circulating adiponectin in human subjects have not yielded unanimous results, with the majority of them, including a recent meta-analysis, reporting significantly higher blood adiponectin levels in AD patients compared to participants without cognitive impairment [26,27]. This evidence concerns the gene ADIPOQ and Cognitive impairment.